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N-Methyl-D-aspartate receptor (NMDAR) activation is implicated in the malig-
nant progression of many cancer types, as previously shown by the growth-
inhibitory effects of NMDAR antagonists. NMDAR-mediated calcium influx
and its downstream signalling depend critically, however, on the dynamics of
membrane potential and ambient glutamate concentration, which are poorly
characterized in cancer cells. Here, we have used low-noise whole-cell patch-
clamp recording to investigate the electrophysiology of glutamate signalling
in pancreatic neuroendocrine tumour (PanNET) cells derived from a geneti-
cally-engineered mouse model (GEMM) of PanNET, in which NMDAR
signalling is known to promote cancer progression. Activating NMDARs
causedexcitationand intracellular calciumelevation, and intracellular perfusion
with physiological levels of glutamate led to VGLUT-dependent autocrine
NMDAR activation. Necrotic cells, which are often present in rapidly-growing
tumours,were shown to release endogenous cytoplasmic glutamate, and necro-
sis induced by mechanical rupture of the plasma membrane produced intense
NMDAR activation in nearby cells. Computational modelling, based on these
results, predicts that NMDARs in cancer cells can be strongly activated in the
tumour microenvironment by both autocrine glutamate release and necrosis.1. Introduction
The N-methyl-D-aspartate receptor (NMDAR) is an ionotropic glutamate recep-
tor which is present at most excitatory glutamatergic synapses in the nervous
system [1,2]. It is calcium-permeable, but blocked in a voltage-dependent way
by extracellular magnesium ions. In the central nervous system (CNS), these
properties enable an activity-dependent switch, turning on downstream kinases
and changes in gene expression which regulate synaptic efficacy [3], neuronal
proliferation and survival [4,5]. Functional NMDAR signalling has been
reported in tissues outside the CNS, for example in skin keratinocytes, during
re-epithelialization following skin injury [6]. Expression of NMDARs has also
been found in a variety of human cancer cell lines [7], and in human small-
cell lung cancer and breast cancer tumours, whose growth in mouse xenografts
is inhibited by NMDAR blockers [8,9], as well as in prostate cancer [10].
AlthoughNMDARexpression has been detected by qRT-PCR orwestern blot-
ting, the electrophysiology of these ectopically-expressed NMDARs in cancer cells
has not been elucidated. Do NMDARsmediate significant membrane current and
calcium influx?What are the sources of their main ligand, glutamate, for their acti-
vation in cancer cells? AreNMDARs activated byautocrine or paracrine glutamate
secretion, or both? Using the RIP1-Tag2 mouse model of pancreatic neuroendo-
crine tumour (PanNET) [11], Li & Hanahan [12] showed that NMDAR
activation is associated with invasive tumour growth, and proposed a model in
which autocrine release of glutamate, stimulated by interstitial fluid flow, causes
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Here, we take advantage of a cancer cell line derived from
this GEMM, and use low-noise whole-cell patch-clamp record-
ing to illuminate the electrophysiology of NMDARs in cancer
cells.
2. Results
2.1. Whole-cell patch-clamp reveals functional NMDAR
ion channels in a mouse model of PanNET
We carried out whole-cell patch-clamp recordings (figure 1a) in
a tumour cell line (bTC-B6) derived from the RIP1-Tag2 trans-
genic mouse model of PanNET bred into the C57BI/6 (B6)
strain [12]. Using internal (high Kþ) and external solutions
mimicking physiological ionic conditions, we found that these
cells were excitable in current-clamp, had high input resistances
(2–8 GV), membrane capacitances of 5–30 pF, and major
inward and outward voltage-dependent currents whose kin-
etics were consistent with the predominant L- and N-type
voltage-gated calcium and Kv2.1 delayed rectifier potassium
currents of normal pancreatic b cells [14]. Next, we used an
intracellular solution in which potassium was replaced by cae-
sium, to reduce baseline noise [15] and allow single-channel
resolution in the whole-cell current [16], and magnesium was
omitted from the extracellular solution, to prevent magnesium
block of NMDARs. Application of L-glutamate or NMDA
caused agonist-activated channel openings (figure 1b,c), whose
amplitude (40–50 pS), reversal potential (0 mV, figure 1d)
and open and closed lifetime distributions figure 1e,f) coincide
with those expected of GluN2A/B-containingNMDA receptors
[17], with a mean open time of 3–5 ms, and a complex closed-
time distribution with at least three exponential components.
2.2. Intracellular calcium activity is influenced by
NMDARs
As described in a separate study [18], activating NMDARs in
these PanNET cells caused depolarization and calcium influx
(figure 2a,b), confirming that bTC-B6 cells express functional
NMDARs which are capable of depolarizing cells to firing
threshold and causing calcium influx. Here, we extended these
observations by showing that sustained calcium activity can
also be initiated by L-glutamate or NMDA (figure 2c(i,ii) in a
physiological concentration (1 mM [19]) of extracellular Mg2þ.
We also often observed repetitive spontaneous calcium transi-
ents, in zero or 1 mM Mg2þ, both at room temperature or
near-physiological 358C (figure 2d). We investigated the effect
of applying APV (50 or 100 mM) to regions of cultures showing
ongoing spontaneous calcium activity. Although APV did not
always block spontaneous calcium activity, we found multiple
regionswhere activitywas clearly silencedwith the onset of per-
fusion (figure 2e). This indicates that NMDARs contribute to
and, in some cases, drive spontaneous activity, which may
also be sustained by other sources of intrinsic excitation.
2.3. NMDARs are activated by paracrine and autocrine
release of glutamate
Glutamate is estimated to be present in the cytoplasm of
neuronal cells at a concentration [Glut]i of 1–10 mM, withapproximately 100 mM concentrated in synaptic vesicles
[20]. In pancreatic b cells, intracellular glutamate concen-
tration has been estimated to be 1–7 mM [21]. The most
direct measurements of cytosolic glutamate in living cells
have been carried out using 13C NMR spectroscopy in prolif-
erating glioblastoma cells, showing it to have a level of
around 20 mM [22].
In morphologically-compact cells such as bTC-B6, the
intracellular compartment is well-perfused in the whole-cell
recording mode, and freely-diffusing glutamate should
equalize in concentration between the 15 ml of pipette
solution and the 2 pl of cytoplasm within seconds [15].
Therefore, to assess autocrine activation, a physiological
level of free cytoplasmic glutamate should be included in
the pipette filling solution, to allow normal rates of glutamate
release [23]. In contrast, a glutamate-free pipette solution
effectively clamps cytoplasmic glutamate concentration to
zero: thus, spontaneous NMDAR channel openings observed
in this condition will reflect only paracrine activation, since
direct efflux or vesicular packaging of glutamate would not
be maintained.
Addition of 1 or 10 mM L-glutamate to the caesium-based
pipette solution (figure 3a) caused a striking activation of
NMDARs (figure 3a) in most cells, which showed the charac-
teristic 45 pS slope conductance, and could be blocked by
perfusion with APV, a specific antagonist of NMDARs
(figure 3d,e). All detectable openings were also abolished by
1 mM [Mg2þ]o (n ¼ 10 cells, not shown). In contrast, when
glutamate was omitted from the pipette solution, only
sparse or no channel openings were seen (figure 3b). We
also carried out nystatin perforated-patch recordings
(see Material and methods) in order to test for NMDAR open-
ing by endogenous cytosolic glutamate. With this technique,
the signal-to-noise level was far lower, but 4–5 pA inward
channel openings were apparent at a holding potential of
290 mV (figure 3c, five cells). We quantified channel activity
by measuring the average number of simultaneously-open
NMDAR channels over periods of 30–60 s (figure 3f ).
1 mM [Glut]i produced about 60% of the activation level for
10 mM [Glut]i. This activation was specific for glutamate, as
10 mM [NMDA]i did not significantly elevate the channel
open probability over control. We conclude that this elevated
NMDAR activity represents autocrine signalling, with release
occurring through a glutamate-specific transport pathway,
and that occasional openings observed with zero-glutamate
intracellular solution represent paracrine activation by gluta-
mate released from other, nearby cells.
To identify the route by which glutamate exits the cell to
cause autocrine activation, we investigated the effect of
specific blockers of glutamate transport on autocrine activity.
Major candidates for pathways of autocrine glutamate release
include the excitatory amino acid transporters (EAATs) [24],
the system xc
2 cystine/glutamate antiporter [25], and the ves-
icular glutamate (VGLUT) transporters [26], which are
known to be expressed in this cell line [12]. Sulfasalazine, a
potent (Ki , 1 mM) and specific blocker of system xc ,
and DL-threo-b-benzyloxyaspartate (DL-TBOA), a specific
blocker of EAATs, failed to reduce channel activity at concen-
trations of 10 mM (n ¼ 4 cells) and 100 mM (n ¼ 6 cells)
respectively. In contrast, Rose Bengal [27], which is a highly
potent, noncompetitive, membrane-permeable blocker of
VGLUTs (Ki ¼ 19 nM), effectively blocked NMDAR currents
at 100 nM (n ¼ 5, figure 3g), and the blockade was reversible
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Figure 1. Functional NMDARs in PanNET cells. (a) Puff application of glutamate. Puffer pipette at left, patch pipette at right. (b) Whole-cell patch recording, 500 Hz
Gaussian digital low-pass filter,280 mV. (c) Expanded segment of top trace in (b) (indicated by horizontal bar) showing single-channel opening and closing transitions.
(d ) Current–voltage plot of channel openings. Each point is data from one cell at one holding potential (n ¼ 21 cells). Best-fit slope conductance (g) for reversal potential
(Erev) of 0 mV was 46.6 pS; and for Erev¼ 25 mV, g ¼ 43.7 pS. (e,f ) Sigworth-Sine plots [13] of channel lifetime distributions in one cell. (e) Open-state durations fitted to
a single exponential distribution (6129 events, bin size ¼ 0.18, missed events cut-off, 0.331 ms indicated by dashed vertical line). t ¼ 3.06 ms. (f ) Closed-state durations,
fitted to a sum of three exponential components (8183 events, bin size ¼ 0.24, a1 ¼ 0.318, t1 ¼ 1.63 ms, a2 ¼ 0.595, t2 ¼ 9.75 ms, a3 ¼ 0.09, t3 ¼ 26.0 ms.
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Rose Bengal did not block responses to exogenously-applied
NMDA (figure 3h). We also tested another VGLUT blocker
that is less membrane-permeable, Trypan Blue [28], and
found that it reduced opening probability irreversibly to
28% and 18% of control in two cells, but had no effect in
two other cells, possibly due to failure of the compound toaccess an intracellular site of action. These data suggest that
the release of glutamate across the plasma membrane is
dependent on VGLUTs, but nonspecific effects of these
inhibitors on some other process of glutamate release
cannot be ruled out.
By monitoring cell membrane capacitance using a 1 kHz
sinusoidal voltage-clamp [29], we were able to detect the
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Figure 2. NMDARs can stimulate membrane depolarization and calcium influx. (a) whole-cell current-clamp recording with high [Kþ] solution in the pipette. A 1s
pulse of L-glutamate containing Ringer solution (500 mM) was applied through a perfusion pipette at the time indicated, causing a large, maintained depolarization
accompanied by action potentials. (b) After loading with Oregon Green BAPTA-1AM, fluorescence was recorded while puff-applying 1 mM NMDA dissolved in the
Ringer solution. Synchronous elevations in intracellular calcium are observed in cells across the field which are exposed to the specific agonist. 90 of 173 cells
analysed (52%) showed detectable responses (average DF/F 6.44% in responding cells) to pressure ejection of glutamate or NMDA. (c) Example calcium responses
in several cells to (i) 20 mM L-glutamate or (ii) 1 mM NMDA. (d ) Three simultaneously-recorded cells showing spontaneous calcium transients, at 358C in 1 mM
Mg2þ extracellular solution. (e) Examples of APV-induced silencing of spontaneous activity in cells from eight different culture dishes. Perfusion with 1 mM APV
occurs during the period indicated by the grey bar.
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Figure 3. Autocrine activation of NMDARs. (a) A constant NMDAR channel activation is observed at 290 mV using pipettes filled with a caesium gluconate based
solution containing 10 mM L-glutamate (autocrine condition). A segment of channel activity at higher time resolution is shown below, as indicated. (b) Very infre-
quent or no NMDAR activation is seen when glutamate is omitted from the patch pipette ( paracrine condition). (c) Nystatin-perforated patch recordings show
poorly-resolved 4–5 pA openings (indicated by black spots). (d ) Channel activity is completely and reversibly blocked by perfusion with 1 mM APV. (e) Puff-per-
fusion of APV solution for 500 ms causes a rapid block in channel openings. Black trace: individual trial. Red trace: ensemble average of 20 successive trials. ( f )
Summary of the channel activity produced by intracellular agonists. The ordinate is the average number of open channels measured over a 5 s period at 290 mV.
Significance: control versus 1 mM Glut, *p, 0.0484; control versus 10 mM Glut, **p, 0.000026; control versus 10 mM NMDA, p. 0.458; Wilcoxon rank sum
test. (g) Sensitivity of autocrine NMDAR activation to a VGLUT inhibitor: (i) Reversible block of autocrine activity by 100 nM Rose Bengal. Npo is the product of
channel number and open probability, equivalent to the mean number of simultaneously-open channels. (ii) Rose Bengal (100 nM) block is significant, **p,
0.0079, Wilcoxon rank test, n ¼ 5 cells. (h) Rose Bengal (100 nM) does not block responses to exogenously applied NMDA (1 mM) in cells recorded with zero
glutamate in the pipette (paracrine condition). A short segment of channel activity is shown at high time resolution below, as indicated.
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with the plasma membrane, in response to depolarizing
steps in voltage-clamp, similar in size and duration toaction potentials (figure 4). There is scope therefore for a ves-
icular mechanism for glutamate release, as proposed by Li &
Hanahan [12], which might be at least partially under the
1 ms
+10
–70
mV
40 fF
500 ms
Figure 4. Depolarization triggers capacitance transients indicative of vesicular
release. Membrane capacitance was monitored by applying a 1 kHz sinusoidal
voltage command (bottom). A brief (100 ms) depolarizing step produces a
fast rise in membrane capacitance, followed by a slow decline back to its
baseline level. Similar results were seen in eight cells.
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dent on voltage-gated calcium channel opening is unlikely
to be triggered at potentials below 270 mV, and voltage-
dependence of autocrine-activated NMDAR current was not
significant over the measured range 290 mV to 270 mV
(not shown). We cannot rule out that channel activity might
be voltage-dependent above 260 mV, as this is outside the
potential range in which we can adequately resolve single
channels in the whole-cell current.
2.4. Properties consistent with GluN2B-containing
NMDARs
The functional NMDARs in this cell type appear to be predo-
minantly GluN2B-containing, based on the following
evidence. Firstly, their high conductance (40–50 pS) is typical
for GluN2A or GluN2B, versus GluN2C/D channels. Second,
openings were largely blocked by applying the GluN2B-
selective antagonist Ro 25-6981 (figure 5a, n ¼ 4 cells).
These findings are consistent with the high GluN2B
expression reported in this cell line [12]. It is possible that
the residual openings seen in the presence of Ro 25-6981 cor-
respond to GluN2A-containing receptors, as GluN2A is also
expressed in these cells, and would have an identical
single-channel current amplitude.
In addition, we estimated the open channel probability of
NMDARs during autocrine activation by measuring the rela-
tive likelihood of multiple simultaneous channel openings
(figure 5b,c). Assuming a functional population of N identical
and independent NMDARs, each opening with probability
po, the frequencies of multiple simultaneous openings
should follow a binomial distribution [30]. We fitted current
amplitude histograms with a multi-Gaussian distribution,
in which the integral of each peak was proportional to the
corresponding binomial probability, for a range of different
assumed N values, larger than or equal to the maximum
number of simultaneously observed open channels
(figure 5c). In six out of seven cells analysed, the least-squares
fit showed an optimum at a small finite value of N, which can
be taken as the size of the population of activated receptors.
In these six cells, the mean N was 7, and the mean open prob-
ability po was 0.107. In the remaining cell, no optimum could
be found: the fit improved progressively with increasing N(up to 40), effectively following a Poisson distribution—the
limit of a binomial model for high N and low po.
Notably, a value of po  0.1 coincides with the maximal
value observed for GluN2B-containing channels when fully
occupied by glutamate [31–34]. The EC50 for glutamate acti-
vation of GluN2B-containing channels is around 1.5 mM, and
the Hill coefficient is about 1.5 [35], suggesting a lower bound
for the glutamate concentration experienced by these chan-
nels in the region of 5–10 mM (e.g. the receptor should be
90% activated at 6.5 mM).2.5. Rupture-induced necrosis releases large amounts of
glutamate
Having established autocrine glutamate release as a potent
mechanism of activating NMDARs in bTC-B6, we further
asked if there could be another source of NMDAR-activating
glutamate in the tumour microenvironment, both in PanNET
and in other types of NMDAR-expressing cancer cells which
may or may not co-express VGLUTs. We were particularly
interested in the effect of necrotic cell death within the
tumour microenvironment, as the poor blood supply in
rapidly-growing tumours can lead to extensive necrosis. In con-
trast to apoptosis, in which cell contents are digested in an
orderly way by surrounding cells, necrotic cell death is defined
by abrupt rupture of the plasma membrane with unrestricted
release of the cell contents. Necrosis can be either unregulated,
where the plasma membrane is ruptured abruptly by physical
forces, or regulated by specific signalling pathways, as in
hypoxia-induced necrosis in tumours [36]. Since intracellular
free glutamate is expected to be on the order of 1–10 mM, as
discussed above, then the diluted contents of a single cell
could in principle fill an extracellular volume 103–104 times
larger with glutamate at a near saturating concentration for
GluN2B-containing receptors. Glutamate released from necrotic
cells could therefore be an extremely potent driver of invasion-
promoting NMDAR signalling in a tumour.
Using bTC-B6 as a model system, we tested this idea by
recording paracrine NMDAR activation ([Glut]i ¼ 0) in one
cell while rupturing the membrane of another cell in its
neighbourhood. A glass micropipette, with a fire-polished
tip, was positioned touching a target cell, abruptly advanced
into and through the cell for a period of 1 s, then withdrawn,
using a piezoelectric manipulator to step the position of the
probe (see electronic supplementary material, video S1).
This caused clear necrosis of the impaled cell, and simul-
taneously a large transient of inward current in the
recorded cell (figure 6a). Necrosis responses could be
recorded multiple times in the same cell by sequentially rup-
turing different neighbouring cells (figure 6b). For ruptured
cells within a radius of 150 mm an average peak current of
5.54+ 0.85 pA (s.e.m., 15 cells) was measured, with channel
activation persisting for at least a minute. We calculated the
timing and amplitude of the rupture-induced glutamate tran-
sient (see Material and methods), and this correlated well
with the time course of channel activity (figure 6a,b, red
traces). We confirmed that the necrosis response could be
blocked by simultaneous perfusion of APV (figure 6c), and
amplitude histogram analysis showed that the current was
largely composed of 4 pA openings (figure 6d,e). In
addition to glutamate, intracellular free aspartate, another
effective NMDAR agonist, which has been estimated at
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Figure 5. Properties characteristic of GluN2B-containing NMDARs. (a) Autocrine-activated NMDAR openings are inhibited by a GluN2B-specific blocker. (i), (ii):
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to this necrosis-induced NMDAR current.
To confirm the ability of necrosis to elevate extracellular
glutamate concentration, we used the compound shikonin
to induce programmed necrosis of bTC-B6 cells. Shikonin
causes RIP1- and RIP3-dependent necroptosis by blocking
pyruvate kinase M2 in tumour cells [37]. Incubation of cells
in 20 mM shikonin caused extensive cell death (figure 7a);
many necrotic ‘ghost’ cells were apparent within six hours.
We then measured extracellular glutamate concentration rela-
tive to control using a fluorescence-based enzymatic assay
(see Material and methods), and found that shikonin-induced
necroptosis is associated with a large release of glutamate
into the extracellular space (figure 7b). The average increment
in glutamate concentration for 300 000 cells ml21 was
4.19 mM (n ¼ 16) relative to the DMSO vehicle control. This
corresponds well with a predicted value of 6 mM, assuming
a cell volume of 2 pl, a cytoplasmic concentration of
10 mM, and necrosis of the entire cell population.3. Discussion
3.1. Functional NMDAR ion channels in cancer cells
NMDAR expression has been observed in various types of
cancer, along with other glutamate receptors, but functional
validation has largely been limited to demonstrating the
effect of receptor blockade on cell survival. So far, electro-
physiological evidence for functional NMDAR expression
in cancer cells is only available in a handful of studies
[7,9,38], with only one study examining detailed single-
channel properties, of GluN2C-containing NMDARs in a
phaeochromocytoma line (PC12) [38]. Here, by resolving
single-channel currents in whole-cell recordings, we show
the first direct electrophysiological evidence for autocrine
and paracrine NMDAR signalling in cancer cells, as well
as the first recordings, to our knowledge, of NMDAR
channel activation by necrotic rupture of surrounding
cells, in any cell type.
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left undergoes necrosis, ruptured by driving an empty glass microprobe rapidly through the cell (see electronic supplementary material, video S1). The moment of
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(c) Comparison of the mean amplitude of a 1 s segment around the peak of the response, for control (n ¼ 15 cells) and in the presence of 50 mM APV (n ¼ 3
cells), showing a near complete block. (d ) Detail of the decay phase of (b), within the period indicated by the black bar. (e) Current amplitude histogram of the
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involve a much more complex 3D environment, interactions
with other cell types in the tumour microenvironment,
blood flow and interstitial fluid flow. Nevertheless, as a
first step, it is important to understand quantitatively how
it operates in a simplified 2D culture. In our experimental
condition, bTC-B6 PanNET cells grow as an adherent mono-
layer, with much more area in contact with the underlying
substrate than with neighbouring cells. If the glutamate
release is uniformly distributed over the membrane, then it
is clear that accumulation of glutamate will be higher under-
neath the cell, against the substrate, than on the upper
surface. We used a computational model assuming steady,
uniform glutamate release and simple diffusion to examine
how glutamate might accumulate in this situation (see elec-
tronic supplementary material, figure S1 for details). This
predicts that to raise the glutamate concentration in the
restricted extracellular compartment beneath a cell to a level
required to fully activate NMDARs (5 mM) would require a
release rate of only around 1025 fmoles/s per mm2 of cell
membrane, equivalent to about 0.02% of the cellular content
of free glutamate per second, assuming 10 mM cytosolic
glutamate concentration, and a cell volume of 2 pl. In the
whole-cell patch clamp, glutamate concentration is clamped
by the relatively massive reservoir of solution in the patch
pipette, but in the unperturbed cell, any net efflux would
have to be compensated by resynthesis.
3.2. Mechanism of release of glutamate
Vesicular release of insulin is well-documented in normal
pancreatic b cells [39], and glutamate has been reported to
be packaged into insulin-containing vesicles by VGLUT3
[40,41]. If glutamate release in bTC-B6 cells were vesicular,
and vesicles are assumed to be 100 nm in diameter (e.g.
large dense-core vesicles are 300 nm diameter, synaptic ves-
icles typically 50 nm) and filled with 100 mM glutamate,
then this level of release would require only 10 vesicles/
cell/second, equivalent to 10 fF of membrane capacitance to
be cycled every second (1 mm2 has a capacitance of 10 fF).
This is just below the resolution of the technique for
monitoring cell capacitance, although depolarization-
triggered capacitance transients were readily resolved by
ensemble averaging (figure 4). We were able to block the
autocrine-activated NMDAR openings with Rose Bengal
(figure 3g), suggesting that it depends on VGLUTs. It is
unlikely, however, to be dependent upon conventional cal-
cium-triggered vesicular release, as we found no voltage-
dependence of channel activation over the range 2100 to
260 mV (as noted earlier, background noise prevents resol-
ution of NMDARs above about 260 mV). It is possible that
there is spontaneous calcium-influx-independent vesicular
release, as in cortical neurons [42]. A considerable fraction
of VGLUTs in central neurons is found in the plasma mem-
brane [43], and thus an alternative scenario is that plasma
membrane VGLUTs might conduct intracellular glutamate
down the large electrochemical gradient to the extracellular
space [26]. In either case, the millimolar cytosolic concentration
of glutamate could be maintained by its close coupling to
the tricarboxylic acid cycle through alpha-keto-glutarate, and
glutamine metabolism, which is an important source of
energy in cancer cells [22]. In this connection, the insensitivity
of intracellular glutamate level in PC12 cells toextracellular glutamate level suggests that intracellular gluta-
mate is tightly regulated by metabolic processes, rather than
being determined by plasma membrane glutamate transport
[44].
3.3. NMDAR activation by necrotic release of glutamate
Our observation of very strong NMDAR responses
to mechanical trauma-induced necrosis of nearby cells
demonstrates an interesting mechanism of paracrine gluta-
mate signalling, which may be of particular significance in
cancer. Necrosis is frequently observed in some cancer
types, and is often associated with a more aggressive disease
and worse prognosis. It can occur as a result of the poor
blood and energy supply in the tumour core, and can also
be caused by some types of chemotherapy. We envision
that glutamate release by necrotic cells in the tumour centre
could be delivered by diffusion and interstitial fluid flow to
the NMDAR-expressing cells at the tumour margin, thus
further promoting tumour growth and invasion. It is quite
likely that necrotic tumour interstitial fluid contains enough
glutamate to produce a saturating activation of NMDARs.
Recently, Eil et al. [45] found that tumour necrosis raises
[Kþ] in tumour interstitial fluid (TIF) by about 7.5-fold over
serum concentration, as cell rupture dumps the cytoplasmic
contents of necrotic cells into the extracellular space, and
the resulting raised [Kþ] inhibits T cell effector function
within the tumour. A calculation, assuming that normal
intracellular [Kþ] is 155 mM, and normal extracellular [Kþ]
is 5 mM [30], predicts that about 1/6 of TIF in their study
would originate from the cytoplasmic contents of necrotic
cells. Therefore, the glutamate concentration of similar TIF
might be on the order of 1 mM, in comparison with a Kd
for glutamate binding to GluN1-GluN2B NMDARs of
1.5 mM. Interestingly, NMDAR expression is also seen in
prostate cancer [10], and metastatic prostate cancer often
becomes neuroendocrine-differentiated [46]. Raised serum
glutamate concentration, which might reflect tumour necro-
sis, has been associated with prostate cancer aggressiveness
and Gleason score, and suggested as a possible metabolic bio-
marker [47].
3.4. Computational model of NMDAR current in
mPanNET cells
The key feature of NMDARs which allows them to serve as
an ‘AND’ gate controlling synaptic plasticity is their mag-
nesium block and consequent voltage-dependence, such
that only the conjunction of presynaptic glutamate release
and postsynaptic depolarization can trigger sufficient calcium
influx for plasticity [3]. Although the majority of our exper-
iments were carried out with nominally zero extracellular
magnesium, in order to be able to optimally detect and
study the NMDARs, we confirmed that both glutamate and
NMDA can trigger repetitive calcium activity in physiologi-
cal (1 mM) extracellular magnesium (figure 2c). Moreover,
ongoing repetitive spontaneous calcium activity is also seen
in 1 mM magnesium at near-physiological temperature
(figure 2d ).
To gain more quantitative insight into how NMDAR cur-
rent in these mPanNET tumour cells is influenced by, and
influences membrane potential in physiological magnesium,
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Figure 8. Effect of excitability and NMDAR voltage-dependence on calcium influx in a computational model. (a) Experimentally-recorded action potential firing in response
to injection of increasing levels of current in current-clamp. (b) Corresponding responses for the model, containing 11 NMDARs. (c) Voltage-clamp currents for a family of
different depolarizations from270 mV, as indicated, showing a small inward CaV current and a long-lasting KV current activated by depolarization. Inset shows the inward
current in more detail. (d ) Corresponding responses of the model. (e) (i) Action potential firing in the model with a bias current of þ4.6 pA and application of 5 mM
glutamate. (ii) The corresponding calcium current (10% of total current) through NMDA receptors. (f ) Action potential firing rate as a function of glutamate concentration,
with a constantþ4.6 pA bias current. (g) Calcium current as a function of glutamate concentration. CaV current (red, scale at right) is much greater than NMDAR calcium
current. Total NMDAR calcium current (blue scale at left) rises steadily with glutamate concentration, apart from a temporary reduction at the point where spike rate rises
most rapidly. The pulse NMDAR calcium current (current greater than half-amplitude, indicated by dotted line in the lower panel of (e)), shows a much sharper threshold
behaviour, also showing an extremely high level over a narrow range of glutamate just above the firing threshold.
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main voltage-gated conductances (CaV1/CaV2, KV2.1)
which drive spike generation in normal mouse pancreatic b
cells from which mPanNETs derive [14], with magnitudesdetermined by our voltage-clamp measurements. The
model (figure 8b,d ) was able to account well for the electrical
responses of cells (figure 8a,c). We then added NMDARs to
the model, at a density of 11 channels per cell, and computed
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currents (figure 8f ), as a function of ambient glutamate con-
centration, injecting a small depolarizing current (4.6 pA)
to bias the cell near to spike threshold. This showed that
the electrical activity of the cell can be strongly controlled
by the extracellular glutamate concentration, with spike
rate increasing from 0 to 2 Hz as glutamate is elevated from
zero to about 1.5 mM. Calcium current through CaV channels
(figure 8g) is also sharply elevated over this range. NMDAR
calcium current (taken as 10% of the total NMDAR cur-
rent [48]) is much smaller than the spike-generating CaV
current, but increases smoothly with extracellular glutamate
concentration, except for a local dip at the point at which
spike rate increases most rapidly (a consequence of redu-
ced driving force during the most depolarized phases of
action potentials, and the increased block during the after-
hyperpolarizations). Calcium influx through NMDARs
in these cells mediates pro-invasive signalling in part by
activating CaMK-II [12], which requires cooperative binding
of calcium to calmodulin, and also exhibits a switch-like
nonlinearity of activation via autophosphorylation. It is rel-
evant, therefore, to evaluate calcium influx specifically
during action-potential-related pulses of NMDAR current.
We integrated the calcium influx during currents exceed-
ing half the maximum amplitude reached during pulses
(figure 8e). This ‘pulse’ NMDAR calcium current had a
much sharper onset with increasing glutamate concentra-
tion, at around 1.5 mM, rising rapidly to a local maximum
(figure 8g, dashed blue curve). Thus, blocking only a rela-
tively small fraction of receptors or glutamate release
might, in principle, be able to reduce NMDAR signalling
by a much higher proportion. Overall, the model shows
that it is biophysically plausible that NMDAR activation
can strongly increase activity in these cells in physiological
magnesium, consistent with what we found in calcium
recordings.3.5. Conclusions
Using sensitive electrophysiological techniques, we have
been able to verify, quantify and model the physiological
mechanisms of NMDAR signalling in cancer cells derived
from a highly invasive GEMM of cancer developed by Li &
Hanahan [12], which involve autocrine and paracrine release
of glutamate—possibly through VGLUTs, activation of func-
tional NMDARs, depolarization and calcium influx. Thus,
this study provides much new biophysical insight into how
cancer cells hijack the neuronal glutamate-to-NMDAR signal-
ling circuit. In addition, we have discovered a novel source of
NMDAR-activating glutamate in the tumour environment,
namely the rupture of cells associated with necrosis. While
mouse PanNET cells serve as a model system for the study
presented here, we envision that similar glutamate-to-
NMDAR signalling pathways may exist in other tumour
types, since NMDAR expression is elevated in a variety of
cancers. Taken together, these findings justify further work
to understand the dynamics of extracellular glutamate in
the complex tumour environment. Inhibition of NMDAR
and VGLUTs should be explored further as therapeutic pos-
sibilities for blocking the invasive growth of cancers with
high NMDAR pathway activity.4. Material and methods
4.1. Cell culture
The mouse bTC-B6 PanNET cell line was derived from a
RIP1-Tag2 mouse model of fully backcrossed C57Bl/6
strain background, and cultured by standard methods. Cells
were maintained in Dulbecco’s Modified Eagle’s Medium
(DMEM) supplemented with 10% fetal bovine serum and
50 U ml21 penicillin and 50 mg ml21 streptomycin, in
Thermo Scientific Nunc Easyflasks (Cat. No. 156367). All cul-
ture media and supplements were from Life Technologies.
Medium was exchanged every two days, and passaging
was carried out at about 30–40% confluence. Cells were
plated on Falcon 35  10 mm cell culture dishes and main-
tained in culture for 1–3 days prior to recording.
4.2. Electrophysiology
Cells were bathed in a magnesium-free Ringer solution, con-
taining (mM): 140 NaCl, 2.5 KCl, 2 CaCl2, 10 glucose, 0.01
glycine, 10 HEPES/Na, pH adjusted to 7.4 with NaOH. For
whole-cell recording, patch pipettes were pulled from capil-
lary glass (Harvard Apparatus, borosilicate glass capillaries,
GC150F-7.5) and filled with a solution containing 105 K glu-
conate, 30 KCl, 10 HEPES/KOH, 4 ATP/Mg, 0.3 GTP Na2, 10
creatine phosphate/Na, pH adjusted to 7.3 with NaOH.
Open pipette resistance was between 5 and 10 MV, and the
membrane potential signal was corrected for nulling of the
liquid junction potential before seal formation. Whole-cell
recordings were established using an Axopatch 200A patch-
clamp amplifier (Axon Instruments) using capacitative
feedback mode to reduce noise, low-pass filtered at 5 kHz
(Bessel, 8-pole) and sampled at 20 kHz or 50 kHz with
16-bit resolution using a National Instruments X-series PCIe
board and custom software written in Matlab/Cþþ. Further
low-pass Gaussian digital filtering at corner frequencies
between 500–1000 Hz was applied offline. Glutamate and
NMDA responses were measured by pressure ejection of ago-
nist dissolved in the Ringer solution, through pipettes with
tip diameters of 10–20 mm, and pressures of 5–10 mBar,
using a custom computer-controlled pressure ejection
system. Recording and perfusion pipettes were positioned
with LM-Mini stepper-motor-controlled micromanipula-
tors (Luigs and Neumann, Ratingen, Germany). Nystatin
perforated patch recordings were carried out as in Akaike
& Harata [49], back-filling pipettes with 150 mM CsCl,
10 mM HEPES and 150 mg ml21 nystatin (pH 7.2), after
dipping tips in the same solution without nystatin. All
recordings were carried out at room temperature (238C).
4.3. Intracellular calcium measurement
To record calcium signals, cells were loaded with the fluor-
escent indicator Oregon Green 488 BAPTA-1 AM (Life
Technologies) at 5 mM for 1 h, and imaged using epifluores-
cence (Olympus IX71 microscope, UMPlan FI 10
objective, X-Cite 120 light source, EXFO Photonic Solutions),
and a sCMOS camera (Zyla 4.1 CL10, Andor). Using custom
programs built with the Matlab Image Processing Toolbox,
cell regions were selected, and the average signals across
pixels in each region were analysed as the change in fluor-
escence (DF ) relative to the baseline level (F ), i.e. DF/F. Cells
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physiology (see above), with or without addition of 1 mM
MgCl2. In some experiments, a near-physiological tempera-
ture (358C) was achieved using power resistors to heat the
microscope stage, and monitored by a thermocouple in the
recording bath.
4.4. Single channel analysis
Channel currents were measured by binning the sampled
waveforms, and fitting amplitude histograms to a probability
density function consisting of a sum of Gaussian distri-
butions, by least-squares:
PðyÞ ¼ C0
s0
ﬃﬃﬃﬃﬃﬃ
2p
p e(ðym0Þ2=2s20)
þ
Xn
i¼1
Ciﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2pðs20 þ is21Þ
q e((yim1m0)2=2ðs20þis21Þ), ð4:1Þ
where s20 is the variance of current in the baseline, s
2
1 is
the variance of open channel current noise for a single chan-
nel, m0 is the baseline current level, m1 is the single channel
current amplitude, and n is the maximum number of chan-
nels simultaneously open. To determine the number of
channels N and their open channel probability, the binomial
distribution was used for the probability of k channels being
simultaneously open:
Ck ¼ n!k!ðn kÞ! p
kð1 pÞnk,
substituted into equation (4.1).
Channel gating transitions were determined by crossing
of the 50% threshold amplitude between open and closed
levels. Dwell-time distributions were fitted by probability
density functions which were sums of exponential
components:
pðtÞ ¼
Xn
i¼1
ai
ti
expðt=tiÞ
by maximum likelihood, applying a scaling correction for
missed short dwell times due to the low-pass filter.
4.5. Capacitance measurement
Membrane capacitance was measured continuously from the
phase lead of current responses to a sinusoidal membrane
potential command signal in whole-cell voltage-clamp
[29,50]. If YðvÞ ¼ Aþ jB is the complex admittance of
the equivalent circuit consisting of the membrane resistance
Rm and Cm in parallel, in series with the access resistance
Ra, then
Cm ¼ 1
vB
ðA2 þ B2  AGÞ2
ðA GÞ2 þ B2 ,
where G ¼ 1=ðRa þ RmÞ. The sinusoidal voltage command
signal had a frequency of 1 kHz, amplitude of 12.5 mV
(peak-to-peak 25 mV) and offset of 290 mV.
4.6. Shikonin-induced glutamate release assay
Shikonin (Sigma, S7576) was dissolved in DMSO at a con-
centration of 34.8 mM, then diluted to a final concentration
of 20 mM in a suspension of cells (300 000 cells ml21) inHank’s Balanced Salt Solution (HBSS). After 90 min of
incubation at 378C, the cells and cell fragments were spun
down and glutamate concentration was measured in the
supernatant, using an Amplex Red glutamic acid assay kit
(Invitrogen) and a Fluostar Omega microplate reader (BMG
Labtech, Ortenberg, Germany), with excitation at 544 nm
and fluorescence detection at 590 nm. A second-order
polynomial function was fitted by least squares to mea-
surements from known glutamate standard solutions,
and inverted to yield glutamate measurements from the
fluorescence intensity measurements.
4.7. Glutamate diffusion model
The diffusion equation @c=@t ¼ Dr2c, describing the concen-
tration c of glutamate around a cell, was solved numerically
in two dimensions, using a finite-difference representation
with spatial compartments of 50  50 nm. The system of
differential equations was solved explicitly in space and
implicitly in time with an adaptive time step (Matlab
ode15s), similarly to the Crank–Nicholson method. D, the
diffusion constant for glutamate, was set at 0.5 mm2 ms21
[51]. The surface of the cell emitted glutamate at a constant
rate q, usually set to 1028 fmoles per mm2 of membrane
surface per ms. Concentration was clamped to zero at the
upper boundary, simulating an absorbing well-stirred gluta-
mate-free bath. The bottom (substrate) and side boundaries
were reflecting. Solutions were evaluated to a time (10 s) by
which an effectively steady-state distribution of glutamate
was reached. The numerical solution method was validated
by its exact correspondence with the analytical solution for
the case of constant release of glutamate from a planar
source [52]. For prediction of necrosis-induced glutamate
transients (figure 6), we used the following analytical sol-
ution for release of a quantum M of glutamate at a single
point on a planar surface, at a distance r:
CðtÞ ¼ 2M
ð4pDtÞ3=2
exp  r
2
4Dt
 
,
where M ¼ 2  10214 moles of glutamate at a distance r ¼
80 mm, and diffusion coefficient D ¼ 0.5 mm2 ms21. This
quantity corresponds to a cell with a volume of 2 pl, contain-
ing 10 mM L-glutamate.
4.8. Modelling of membrane currents
A single-compartment electrical model of a cell was speci-
fied from our recorded passive electrical parameters and
voltage-clamp data for active currents (figure 8), and
previously-described Hodgkin–Huxley kinetic models for
CaV and KV2.1 currents: The following set of simultaneous
ordinary differential equations was used. For membrane
potential V:
dV
dt
¼ INMDA þ ICa þ IK þ Ileak þ Ibias
C
,
where the cell capacitance C was set to 16.5 pF. The NMDA
receptor current was given by
INMDA ¼ ½Glut
H
Kd þ ½GlutH
NpmaxgðENMDA  VÞ
ð1þ K1exp( K2VÞÞ ,
where the Hill coefficient H was 1.5, Kd was 1.5 mM, pmax was
0.1 (open probability when fully activated), and the total
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alent to 1 mM Mg2þ) and K2 was 0.06 [53]. The calcium
current was as described in Migliore et al. [54]:
ICa¼ gCam2hV
½Ca2þe expðBVÞ  ½Ca2þi
1 expðBVÞ :
With B ¼ 0.07486 mV21, [Ca2þ]i ¼ 50 nM, [Ca2þ]e ¼ 1 mM,
and
dm
dt
¼ amð1mÞ  bmm,
where
amðVÞ ¼ ð0:1967ð19:88 VÞÞ=ðexp(ð19:88 VÞ=10:0) 1:0Þ,
and bmðVÞ ¼ 0:046 exp( V=20:73Þ (units of ms21).
dh
dt
¼ ahð1 hÞ  bhh,
where ahðVÞ ¼ 0:00016 expðV=48:4Þ and
bhðVÞ ¼ 1= ðexpðð39 VÞ=10Þ þ 1Þ.
KV2.1 current was modelled as described in VanDongen
et al. [55]:
IK ¼ gKnðEK  VÞdn
dt
¼ n1  n
tn
, where n1ðVÞ ¼ 11þ exp(ð9:2 VÞ=6:6Þ
and tnðVÞ ¼ 1001þ exp(ðV þ 46:56Þ=44:14Þ ðmsÞ:
All Matlab code used in simulations is given in the electronic
supplementary material.Data accessibility. No data deposition is applicable for this paper.
A video and all modelling code are provided as electronic
supplementary material.
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